Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlene Chan

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Free Radical Research|November 26, 2019
The role of pigment epithelium-derived factor in protecting against cellular stressNaomi Brook, Emily Brook, Arun Dharmarajan, et al.
BMC Cancer|November 27, 2012
A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic diseaseArlene Chan, Adrienne Morey, Belinda Brown, et al.
Molecular and Cellular Endocrinology|October 29, 2022
Pigment epithelium-derived factor downregulation in oestrogen receptor positive breast cancer bone metastases is associated with menopauseNaomi Brook, Jespal Gill, HuiJun Chih, et al.
Critical Reviews in Oncology/Hematology|April 22, 2011
Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumorsArlene Chan, Shailendra Verma, Sibylle Loibl, et al.
JCO Precision Oncology|December 6, 2024
Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast CancerArlene Chan, Jespal Gill, HuiJun Chih, et al.
Psycho-Oncology|November 17, 2019
Psychosocial consequences in offspring of women with breast cancerArlene Chan, Christopher Lomma, HuiJun Chih, et al.
Breast (Edinburgh, Scotland)|July 27, 2018
Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimensArlene Chan, Astrid Bauwens, Sally Pontre, et al.
Oncoimmunology|April 14, 2017
A review of the importance of immune responses in luminal B breast cancerDelia J Nelson, Briony Clark, Kylie Munyard, et al.
Japanese Journal of Clinical Oncology|June 15, 2010
Management of ErbB2-positive breast cancer: insights from preclinical and clinical studies with lapatinibCharles Vogel, Arlene Chan, Brunilde Gril, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2021
Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in AustraliaArlene Chan, Christopher Lomma, HuiJun Chih, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Free Radical Research|November 26, 2019
The role of pigment epithelium-derived factor in protecting against cellular stressNaomi Brook, Emily Brook, Arun Dharmarajan, et al.
BMC Cancer|November 27, 2012
A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic diseaseArlene Chan, Adrienne Morey, Belinda Brown, et al.
Molecular and Cellular Endocrinology|October 29, 2022
Pigment epithelium-derived factor downregulation in oestrogen receptor positive breast cancer bone metastases is associated with menopauseNaomi Brook, Jespal Gill, HuiJun Chih, et al.
Critical Reviews in Oncology/Hematology|April 22, 2011
Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumorsArlene Chan, Shailendra Verma, Sibylle Loibl, et al.
JCO Precision Oncology|December 6, 2024
Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast CancerArlene Chan, Jespal Gill, HuiJun Chih, et al.
Psycho-Oncology|November 17, 2019
Psychosocial consequences in offspring of women with breast cancerArlene Chan, Christopher Lomma, HuiJun Chih, et al.
Breast (Edinburgh, Scotland)|July 27, 2018
Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimensArlene Chan, Astrid Bauwens, Sally Pontre, et al.
Oncoimmunology|April 14, 2017
A review of the importance of immune responses in luminal B breast cancerDelia J Nelson, Briony Clark, Kylie Munyard, et al.
Japanese Journal of Clinical Oncology|June 15, 2010
Management of ErbB2-positive breast cancer: insights from preclinical and clinical studies with lapatinibCharles Vogel, Arlene Chan, Brunilde Gril, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2021
Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in AustraliaArlene Chan, Christopher Lomma, HuiJun Chih, et al.
Pageof 9